These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 12141829)

  • 41. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between Helicobacter pylori infection and cirrhosis in patients with chronic hepatitis C virus.
    Queiroz DM; Rocha AM; Rocha GA; Cinque SM; Oliveira AG; Godoy A; Tanno H
    Dig Dis Sci; 2006 Feb; 51(2):370-3. PubMed ID: 16534683
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of interferon therapy on Japanese chronic hepatitis C virus patients with anti-liver/kidney microsome autoantibody type 1.
    Iijima Y; Kato T; Miyakawa H; Ogino M; Mizuno M; Sugihara K; Ando T; Fujiwara K; Orito E; Ueda R; Mizokami M
    J Gastroenterol Hepatol; 2001 Jul; 16(7):782-8. PubMed ID: 11446887
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis C virus infection in chronic liver disease in Natal.
    Soni PN; Tait DR; Gopaul W; Sathar MA; Simjee AE
    S Afr Med J; 1996 Jan; 86(1):80-3. PubMed ID: 8685789
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low frequency of Helicobacter DNA in benign and malignant liver tissues from Baltimore, United States.
    Vivekanandan P; Torbenson M
    Hum Pathol; 2008 Feb; 39(2):213-6. PubMed ID: 17949788
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
    Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
    Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection.
    Shibata M; Morizane T; Uchida T; Yamagami T; Onozuka Y; Nakano M; Mitamura K; Ueno Y
    Lancet; 1998 Jun; 351(9118):1773-7. PubMed ID: 9635950
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Detection of hepatitis C virus RNA in cells with hepatocellular carcinoma and its practical significance by in situ polymerase chain reaction].
    Zeng WZ; Jian MD; Chu GZ
    Zhonghua Nei Ke Za Zhi; 1994 Nov; 33(11):747-50. PubMed ID: 7600863
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Host response to the presence of Helicobacter spp. DNA in the liver of patients with chronic liver diseases.
    Rybicka M; Nakonieczna J; Stalke P; Bielawski KP
    Pol J Microbiol; 2011; 60(2):175-8. PubMed ID: 21905637
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Variations in DEPDC5 gene and its association with chronic hepatitis C virus infection in Saudi Arabia.
    Al-Anazi MR; Matou-Nasri S; Abdo AA; Sanai FM; Khan MQ; Albenmousa A; Al-Ashgar HI; Khalaf NZ; Al-Ahdal MN; Al-Qahtani AA
    BMC Infect Dis; 2014 Dec; 14():632. PubMed ID: 25551790
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Outcome of hepatitis C virus infection in Chinese paid plasma donors: a 12-19-year cohort study.
    Rao HY; Sun DG; Yang RF; Liu F; Wang J; Feng B; Wu N; Fang JL; Song GJ; Ma H; Guo F; Wang JH; Li XB; Jin Q; Qin H; Zhuang H; Wei L
    J Gastroenterol Hepatol; 2012 Mar; 27(3):526-32. PubMed ID: 21871021
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The biological significance of serum complements C3 and C4 in HCV-related chronic liver diseases and hepatocellular carcinoma.
    Ali OS; Abo-Shadi MA; Hammad LN
    Egypt J Immunol; 2005; 12(2):91-9. PubMed ID: 17977214
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis.
    Izzo F; Cremona F; Ruffolo F; Palaia R; Parisi V; Curley SA
    Ann Surg; 1998 Apr; 227(4):513-8. PubMed ID: 9563539
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Liver resection for hepatocellular carcinoma in patients with metabolic syndrome: A multicenter matched analysis with HCV-related HCC.
    Viganò L; Conci S; Cescon M; Fava C; Capelli P; D'Errico A; Torzilli G; Di Tommaso L; Giuliante F; Vecchio FM; Salizzoni M; David E; Pinna AD; Guglielmi A; Capussotti L
    J Hepatol; 2015 Jul; 63(1):93-101. PubMed ID: 25646890
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of Helicobacter pylori in paraffin-embedded specimens from patients with chronic liver diseases, using the amplification method.
    Pirouz T; Zounubi L; Keivani H; Rakhshani N; Hormazdi M
    Dig Dis Sci; 2009 Jul; 54(7):1456-9. PubMed ID: 18975076
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunohistochemical evaluation of oxidative stress markers in chronic hepatitis C.
    Mahmood S; Kawanaka M; Kamei A; Izumi A; Nakata K; Niiyama G; Ikeda H; Hanano S; Suehiro M; Togawa K; Yamada G
    Antioxid Redox Signal; 2004 Feb; 6(1):19-24. PubMed ID: 14713333
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Coinfection of
    Madala S; MacDougall K; Surapaneni BK; Park R; Girotra M; Kasi A
    J Clin Med Res; 2021 Dec; 13(12):530-540. PubMed ID: 35059071
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
    Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of SEN virus on immunoblot INNO-LIA HCV reactivity pattern and disease outcome in Egyptian hepatocellular carcinoma patients.
    Alam El-Din HM; Abo-Shadi MA; Helal A
    Egypt J Immunol; 2007; 14(1):1-10. PubMed ID: 18689276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.